Eli Lilly and Co(us:LLY)
805.23
-2.50%
Updated on 2025-04-02
Open:818.60
Close:805.23
High:820.66
Low:797.00
Prev Close:825.91
Volume:2.99M
Turnover:2.41B
Turnover Ratio:0.32%
Shares:947.99M
MarketCap:763.35B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 126 | 1325085 | 0.14% | 7 | 56 | 45 |
| 2024-03-31 | 3413 | 769377007 | 80.95% | 327 | 1350 | 1351 |
| 2023-12-31 | 3221 | 782592074 | 82.43% | 381 | 1184 | 1286 |
| 2023-09-30 | 2947 | 775866351 | 81.73% | 270 | 1033 | 1234 |
| 2023-06-30 | 2775 | 772899302 | 81.42% | 272 | 1033 | 1124 |
| 2023-03-31 | 2633 | 826000203 | 87.01% | 130 | 1016 | 1106 |
| 2022-12-31 | 2674 | 787699796 | 82.90% | 292 | 926 | 1090 |
| 2022-09-30 | 2493 | 816348134 | 85.92% | 138 | 919 | 991 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Lilly Endowment Inc | 97367369 | 10.24% | -1531441 | -1.55% |
| 2024-06-30 | Vanguard Group Inc | 73859008 | 7.77% | 1113997 | 1.53% |
| 2024-06-30 | Blackrock Inc. | 65856195 | 6.93% | 581810 | 0.89% |
| 2024-06-30 | Pnc Financial Services Group, Inc. | 51404836 | 5.41% | -33360 | -0.07% |
| 2024-06-30 | State Street Corp | 33877562 | 3.56% | -381004 | -1.11% |
| 2024-06-30 | Fmr Llc | 33488021 | 3.52% | -594457 | -1.74% |
| 2024-06-30 | Capital World Investors | 21813763 | 2.30% | -2722292 | -11.10% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 20651736 | 2.17% | 38675 | 0.19% |
| 2024-06-30 | Primecap Management Co/Ca/ | 19618082 | 2.06% | -1636108 | -7.70% |
| 2024-06-30 | Jpmorgan Chase & Co | 18838691 | 1.98% | -364272 | -1.90% |
About
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Address:Lilly Corporate Center
Website:http://www.lilly.com
Market Movers